Please select a Capability in order to start your service request.
Learn about the dangers of hazardous drug exposure―they are studied, documented and very real
About 8 million U.S. healthcare workers, including pharmacists, physicians and other caregivers, are potentially exposed to hazardous drugs, according to the CDC.1 This exposure is putting them at risk of both short- and long-term health issues such as headaches, hair loss, nausea, organ damage, reproductive problems,2 developmental impairment, genetic issues and even cancer.3
To address these risks, healthcare facilities need to comply with new and existing standards, guidelines and recommendations. With changes driven by USP General Chapter <800> Hazardous Drugs—Handling in Healthcare Settings, facilities should use a closed system drug transfer device (CSTD) when compounding hazardous drugs when the dosage form allows, and CSTDs must be used when administering antineoplastic hazardous drugs when the dosage form allows.4
The BD hazardous drug safety portfolio offers a comprehensive array of products—including the next generation BD PhaSeal? Optima system, the BD PhaSeal? system and the Texium? system to help protect workers from hazardous drug exposure, and the BD? HD Check system to help detect* hazardous drug surface contamination for select hazardous drugs.** Backed by its vast clinical expertise and experience, BD also partners with healthcare facilities, offering tailored solutions that best meet their needs for safety, efficiency and cost. We offer ongoing training and education programs and product support tools and services to maximize their investments in protection.
*Surfaces with contamination at or above the limits of detection have 95% specificity and sensitivity
**Methotrexate, doxorubicin, cyclophosphamide
†For a select number of hazardous drugs: methotrexate, doxorubicin and cyclophosphamide